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Aims
To determine the efficacy of antidepressants for treating
idiopathic orofacial pain fulfilling the International Clas-
sification of Headache Disorders 2nd edition (ICHD-II)
criteria of persistent idiopathic facial pain (13.18.4; IFP)
or burning mouth syndrome (13.18.5; BMS).
Materials and methods
Participants comprised 195 outpatients who attended our
orofacial pain liaison clinic between January 1, 2009 and
December 31, 2011 and were diagnosed with IFP or BMS.
IFP was diagnosed in 124 patients (17 men, 107 women;
atypical facial pain, n=16; atypical odontalgia, n=108), with
a mean age of 54.8 ±14.4 years and a mean duration of
illness of 50.7 ± 62.8 months. BMS was diagnosed in
71 patients (8 men, 63 women; so-called BMS, n=28; glos-
sodynia (pain limited to tongue), n=43), with a mean age
of 67.2 ± 10.8 years and a mean duration of illness of 23.1
± 27.3 months. Patients with mental disorders, including
major depressive disorders, who were currently taking
antipsychotic agents were excluded. All participants were
treated with antidepressants, with first-line therapy com-
prising amitriptyline or another tricyclic antidepressant
(TCA). If a TCA alone proved insufficient for pain control,
one of the following agents was added to the TCA for
combination therapy, in this order: risperidone; sodium
valproate; or lithium. These other antidepressants were
also used if the patient could not use TCAs due to under-
lying disease. Outcomes were assessed as: -effective, pain
disappeared or no pain was experienced for 90% of each
week; -moderately effective, pain improved, but did not
disappear; -no effect, no change; and dropped out, includ-
ing referral due to difficulty making visits because of the
distance.
Results
For IFP, treatment was effective for 91 patients (73.4%),
moderately effective, 3.2%, no effect, 0%, dropped out,
23.4%. For BMS, treatment was effective for 56 patients
(78.9%), moderately effective, 4.2%, no effect, 1.4%,
dropped out, 15.5%.
Discussion
Use of antidepressants can be helpful in the treatment
of idiopathic orofacial pain such as IFP or BMS.
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